Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Valiant Co.,Ltd (002643.SZ)
Yantai, CN
Valiant Co.,Ltd., a global enterprise established in 1992, specializes in the worldwide production and distribution of an extensive array of chemical materials. The company's diverse product portfolio primarily encompasses electronic chemicals, including components and intermediates vital for liquid crystal displays (LCDs) and organic light-emitting diodes (OLEDs), as well as polyimide (PI) materials, photoresist (PR) monomers, and crucial additives for lithium-ion batteries. Beyond electronics, Valiant provides various specialized materials for environmental and industrial applications. These include substances for automotive exhaust purification, catalysts for flue gas denitrification, volatile organic compound (VOC) adsorption, methanol-to-olefin conversion, and petroleum cracking. Furthermore, the company contributes to the new energy sector with advanced materials, energy-efficient lighting solutions, organic solar technologies, and ancillary components for electric vehicles. Valiant's operations also extend into the life sciences and healthcare domains. It manufactures Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and finished drug formulations, alongside traditional Chinese medicine products and nutritional health supplements. The company supports scientific research through life science products and services relevant to drug innovation, genomics, proteomics, metabolomics, and food health analysis. Additionally, Valiant develops diagnostic reagents essential for identifying human diseases such as AIDS, hepatitis, cancer, dengue fever, and cardiovascular/cerebrovascular conditions, as well as for detecting drug abuse, endocrine levels, and other physiological parameters. Originally known as Yantai Valiant Fine Chemicals Co., Ltd., the company rebranded to Valiant Co.,Ltd. in May 2015. It is headquartered in Yantai, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.00% | -12.44% | -10.11% | -16.95% | +4.58% | -0.93% | +32.12% | -7.36% | -12.18% | -18.23% | +195.82% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+0.6% Q1'26: +17.9% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+19.2% ★ Q1'26: +11.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+13.1% Q1'26: -3.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+11.2% ★ Q1'26: +13.1% (vs Q1'25)
-
ROIC Chemicals: +3.4%+4.9% ★ Q1'26: +5.8% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-3.1% ★ Q1'26: -1.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.73× ★ Q1'26: 3.28× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.63B
est: 1.53B (+6.5%)
|
1.85B
est: 1.85B (+0.0%)
|
2.46B
est: 2.43B (+1.0%)
|
2.63B
est: 2.70B (-2.4%)
|
2.87B
est: 2.88B (-0.4%)
|
2.92B
est: 2.96B (-1.5%)
|
4.04B
est.
|
4.36B
est: 5.21B (-16.4%)
|
5.08B
est: 4.49B (+13.1%)
|
4.31B
est: 4.49B (-4.2%)
|
3.69B
est: 3.70B (-0.2%)
|
3.72B
est: 3.83B (-3.0%)
|
4.31B
4.25B – 4.38B
+12.6% YoY
|
4.78B
4.55B – 5.08B
+10.9% YoY
|
5.37B
5.19B – 5.59B
+12.3% YoY
|
| EBITDA |
398.63M
est: 383.42M (+4.0%)
|
558.48M
est: 462.46M (+20.8%)
|
632.32M
est: 609.19M (+3.8%)
|
721.59M
est: 675.36M (+6.8%)
|
853.85M
est: 721.84M (+18.3%)
|
664.74M
est: 741.75M (-10.4%)
|
1.01B
est.
|
1.08B
est: 1.31B (-17.1%)
|
1.38B
est: 1.13B (+22.6%)
|
1.42B
est: 1.13B (+26.3%)
|
874.62M
est: 978.08M (-10.6%)
|
871.44M
est: 1.01B (-13.9%)
|
1.14B
1.12B – 1.16B
+12.6% YoY
|
1.26B
1.20B – 1.34B
+10.9% YoY
|
1.42B
1.37B – 1.48B
+12.3% YoY
|
| EBIT |
298.37M
est: 270.68M (+10.2%)
|
399.79M
est: 326.48M (+22.5%)
|
447.39M
est: 430.07M (+4.0%)
|
504.08M
est: 476.78M (+5.7%)
|
619.35M
est: 509.60M (+21.5%)
|
646.78M
est: 523.65M (+23.5%)
|
714.76M
est.
|
789.06M
est: 921.82M (-14.4%)
|
982.16M
est: 794.25M (+23.7%)
|
986.43M
est: 794.25M (+24.2%)
|
447.77M
est: 619.31M (-27.7%)
|
415.57M
est: 640.89M (-35.2%)
|
721.55M
710.57M – 732.53M
+12.6% YoY
|
800.05M
761.16M – 849.79M
+10.9% YoY
|
898.60M
868.90M – 934.81M
+12.3% YoY
|
| Net Income |
257.85M
est: 290.48M (-11.2%)
|
318.65M
est: 365.63M (-12.8%)
|
385.28M
est: 435.72M (-11.6%)
|
444.48M
est: 465.49M (-4.5%)
|
506.71M
est: 532.81M (-4.9%)
|
504.71M
est: 546.58M (-7.7%)
|
691.65M
est.
|
626.66M
est: 835.53M (-25.0%)
|
721.33M
est: 794.63M (-9.2%)
|
763.01M
est: 794.63M (-4.0%)
|
246.28M
est: 415.43M (-40.7%)
|
284.48M
est: 367.36M (-22.6%)
|
489.80M
468.76M – 515.46M
+33.3% YoY
|
550.49M
526.84M – 579.32M
+12.4% YoY
|
630.09M
603.02M – 663.10M
+14.5% YoY
|
| SGA |
278.91M
est: 171.85M (+62.3%)
|
370.35M
est: 207.28M (+78.7%)
|
339.79M
est: 273.04M (+24.4%)
|
353.31M
est: 302.70M (+16.7%)
|
350.64M
est: 323.53M (+8.4%)
|
329.76M
est: 332.45M (-0.8%)
|
453.78M
est.
|
419.24M
est: 585.24M (-28.4%)
|
565.35M
est: 504.25M (+12.1%)
|
484.03M
est: 504.25M (-4.0%)
|
473.54M
est: 356.17M (+33.0%)
|
122.60M
est: 368.58M (-66.7%)
|
414.97M
408.66M – 421.28M
+12.6% YoY
|
460.11M
437.75M – 488.72M
+10.9% YoY
|
516.79M
499.71M – 537.62M
+12.3% YoY
|
| EPS |
0.31
est: 0.31 (+1.1%)
|
0.37
est: 0.39 (-4.1%)
|
0.42
est: 0.46 (-8.7%)
|
0.49
est: 0.49 (-0.3%)
|
0.56
est: 0.56 (-0.4%)
|
0.56
est: 0.58 (-3.0%)
|
0.73
est.
|
0.69
est: 0.88 (-21.8%)
|
0.79
est: 0.84 (-5.8%)
|
0.84
est: 0.84 (+0.1%)
|
0.26
est: 0.45 (-42.6%)
|
0.31
est: 0.40 (-22.6%)
|
0.53
0.51 – 0.56
+33.3% YoY
|
0.60
0.57 – 0.63
+12.4% YoY
|
0.69
0.66 – 0.72
+14.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-25 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.01% | 55.9K | 0.49% |
| 2 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.01% | 1.74M | 0.07% |
| 3 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 152.4K | 0.19% |
| 4 | Franklin FTSE China ETF FLCH | 0.01% | 17.5K | 0.19% |
| 5 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.01% | 525.6K | 0.39% |
| 6 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 102.4K | 0.46% |
| 7 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 258.5K | 0.28% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 12.3K | 0.44% |
| 9 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 188.8K | 0.29% |
| 10 | Schwab Emerging Markets Equity ETF SCHE | 0.00% | 221.6K | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Baohua Hu | Deputy General Manager | — | male |
| Gao Bin | Chief Financial Officer & Accounting Supervisor | — | male |
| Huan Jie Wang | Deputy General Manager | — | male |
| Ji Hua Wang | Deputy General Manager | — | male |
| Shaobang Fu | Deputy General Manager | — | male |
| Shu Min Yu | Board Secretary | — | male |
| Zhong Li Wang | General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002643.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
